Lipid management in Qatar in High CV-risk Patients: Why do we need novel therapeutics?
Educational information
This session is recorded at Master Class - PCSK9 Inhibition in Clinical Lipid Management
Disclosures
Dr Hani Sabbour is Consultant Cardiologist and Electrophysiologist -Clinical Professor of Cardiology, Cardiology Department Sheikh Khalifa Medical Center, Abu Dhabi , UAE
Funding
The meeting was sponsored by Sanofi Gulf
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: